Abstract:Highlights • Parthanatos, a type of cell death characterized by its close interaction between the cell nucleus and mitochondria, plays a key role in CNS injury. • Parthanatos are initiated by the over-activation of PARP-1, causing large fragments of DNA and leading to cell death. Other types of cell death could interact with Parthanatos such as apoptosis, autophagy and mitophagy. • In the pathological process of CNS injury, the consequences of damage, such as excitotoxicity and oxidative stress caused by injury, can activate Parthanatos. This cell death pathway can also mediate inflammation and exacerbate the damage. • Parthanatos occurs in different types of cells in CNS injury, including microglia, endothelial cells, oligodendrocytes, astrocytes and neural precursor cells. • Specifically blocking Parthanatos represents a promising novel therapeutic strategy for CNS injury. Background Central nervous system (CNS) injury causes severe organ damage due to both damage resulting from the injury and subsequent cell death. However, there are currently no effective treatments for countering the irreversible loss of cell function. Parthanatos is a poly (ADP-ribose) polymerase 1 (PARP-1)-dependent form of programmed cell death that is partly responsible for neural cell death. Consequently, the mechanism by which parthanatos promotes CNS injury has attracted significant scientific interest. Aim of review Our review aims to summarize the potential role of parthanatos in CNS injury and its molecular and pathophysiological mechanisms. Understanding the role of parthanatos and related molecules in CNS injury is crucial for developing effective treatment strategies and identifying important directions for future in-depth research. Key scientific concepts of review Parthanatos (from Thanatos, the personification of death according to Greek mythology) is a type of programmed cell death that is initiated by the overactivation of PARP-1. This process triggers a cascade of reactions, including the accumulation of poly(ADP-ribose) (PAR), the nuclear translocation of apoptosis-inducing factor (AIF) after its release from mitochondria, and subsequent massive DNA fragmentation caused by migration inhibitory factor (MIF) forming a complex with AIF. Secondary molecular mechanisms, such as excitotoxicity and oxidative stress-induced overactivation of PARP-1, significantly exacerbate neuronal damage following initial mechanical injury to the CNS. Furthermore, parthanatos is not only associated with neuronal damage but also interacts with various other types of cell death. This review focuses on the latest research concerning the parthanatos cell death pathway, particularly considering its regulatory mechanisms and functions in CNS damage. We highlight the associations between parthanatos and different cell types involved in CNS damage and discuss potential therapeutic agents targeting the parthanatos pathway. Graphical abstract Download : Download high-res image (100KB) Download : Download full-size image

Activation of PARP in Secondary Brain Injury Following Intracerebral Haemorrhage

PARP Inhibition Attenuates Early Brain Injury Through NF-κB/MMP-9 Pathway in a Rat Model of Subarachnoid Hemorrhage.

[Roles of Protease-Activated Receptor-1 in Thrombin-Induced Brain Injury and Neurogenesis in Rats].

PARP-1 dependent cell death pathway (Parthanatos) mediates early brain injury after subarachnoid hemorrhage

Exploring the role of parthanatos in CNS injury: Molecular insights and therapeutic approaches

The role of PARP-1 on brain ischemia injury and brain-protection therapy

The PERK Pathway Plays a Neuroprotective Role During the Early Phase of Secondary Brain Injury Induced by Experimental Intracerebral Hemorrhage

Par-1 Antagonist Sch79797 Ameliorates Apoptosis Following Surgical Brain Injury Through Inhibition of Ask1-Jnk in Rats

Ischemic Brain Injury is Mediated by the Activation of Poly(Adp-Ribose)Polymerase

Targeting Parthanatos in Ischemic Stroke

PERK Pathway Activation Promotes Intracerebral Hemorrhage Induced Secondary Brain Injury by Inducing Neuronal Apoptosis Both in Vivo and in Vitro

Secondary Brain Injury by Oxidative Stress After Cerebral Hemorrhage: Recent Advances

Research progress on damage-associated molecular patterns in intracerebral hemorrhage

Neuroprotective Therapies for Spontaneous Intracerebral Hemorrhage

The advance of poly ADP-ribose polymerase-1 and poly ADP-ribose polymerase-1-dependent cell death in nervous system diseases

Mitochondria: Novel Mechanisms and Therapeutic Targets for Secondary Brain Injury After Intracerebral Hemorrhage

Secondary mechanisms of injury and viable pathophysiological targets in intracerebral hemorrhage

Poly (Adp-Ribose) Polymerase-1 and Ischemic Brain Injury

Potential Role of Poly (Adp-Ribose) Polymerase in Delayed Cerebral Vasospasm Following Subarachnoid Hemorrhage in Rats.

Activation of PPAR-β/δ Attenuates Brain Injury by Suppressing Inflammation and Apoptosis in a Collagenase-Induced Intracerebral Hemorrhage Mouse Model

Microglia Activation and Polarization After Intracerebral Hemorrhage in Mice: the Role of Protease-Activated Receptor-1